Aspirin May Improve Survival in PIK3CA-Mutated Colorectal Cancers

Aspirin May Improve Survival in PIK3CA-Mutated Colorectal Cancers
Patients with the mutation who used aspirin regularly after initial diagnosis of their colorectal cancer had an 82% reduction in death from colorectal cancer and a 40% reduction in death overall compared to patients who had the PIK3CA mutation but did …

Full News here – Read more on Cancer Network

Leave a Reply